ICL News and Press, Israel Chemicals Limited From 12/19/23

Company prioritizing R&D capabilities, as it looks to lead in North American lithium iron phosphate battery materials market ICL (NYSE: ICL) (TASE: ICL ) , a leading global specialty minerals company, today announced plans to invest $30 million to develop a custome...

2023-12-10 10:04:19 ET Summary Invesco DB Agriculture Fund ETF has recovered to within 5% of its Q2 2022 high. ICL Group is ranked no. 6 in the global potash industry and no. 2 in the bromine industry. ICL's earnings are expected to fall sharply this year, but the stock is und...

2023-11-14 15:28:48 ET More on Nutrien and Mosaic Deep Value: Why Nutrien Remains Significantly Undervalued Nutrien Q3 2023 Results - Earnings Call Presentation Mosaic: A Very Bullish Message For Shareholders For further details see: Nutrien, Mosaic jump ...

2023-11-08 15:07:06 ET ICL Group Ltd (ICL) Q3 2023 Earnings Conference Call November 8, 2023 08:30 ET Company Participants Peggy Reilly Tharp - Vice President of Global Investor Relations Raviv Zoller - President & Chief Executive Officer Aviram Lahav - Chief...

2023-11-08 08:45:45 ET More on ICL Group ICL Group: Cheap Valuation Given The Market Opportunities ICL - What Happens To The Dividend With FY EBITDA Poised To Decline By 55-60%? ICL Group Non-GAAP EPS of $0.11 beats by $0.02, revenue of $1.9B; reaffirms FY23 outlook ...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

ICL Group Ltd. (ICL) is expected to report $0.09 for Q3 2023

2023-11-08 02:25:38 ET More on ICL Group ICL Group: Cheap Valuation Given The Market Opportunities ICL - What Happens To The Dividend With FY EBITDA Poised To Decline By 55-60%? War between Israel and Hamas pushes U.S.-traded Israeli stocks lower For further ...

Delivers sales of $1.9 billion, flat sequentially, with adjusted EBITDA of $346 million, diluted earnings per share of $0.11 and continued strong cash generation Reaffirms full year adjusted EBITDA guidance ICL (NYSE: ICL) (TASE: ICL) , a leading global specialty min...

2023-11-07 12:37:39 ET More on ICL Group ICL Group: Cheap Valuation Given The Market Opportunities ICL - What Happens To The Dividend With FY EBITDA Poised To Decline By 55-60%? ICL Group Ltd 2023 Q2 - Results - Earnings Call Presentation War between Israel a...